UAB "Lotos pharma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 2,121,295 |
| 224,713 |
| 431,271 |
| 362,167 |
| 38,365 |
| 44.18 |
| 17.07 |
| 1,276,152 |
| 515,937 |
| 32,491 |
| 1,817,805 |
| 2023 |
|---|
| 1,986,806 |
| 225,517 |
| 281,967 |
| 232,782 |
| 26,422 |
| 43.42 |
| 11.72 |
| 1,095,992 |
| 594,082 |
| 18,664 |
| 1,667,765 |
| 2024 |
|---|
| 1,665,695 |
| 200,445 |
| -85,888 |
| -85,888 |
| -10,335 |
| 39.81 |
| -5.16 |
| 939,516 |
| 1,096,952 |
| 50,816 |
| 1,991,331 |
Register and
explore Okredo data| 2024 |
|---|
| 1,665,695 |
| 200,445 |
| -85,888 |
| -85,888 |
| -10,335 |
| 39.81 |
| -5.16 |
| 939,516 |
| 1,096,952 |
| 50,816 |
| 1,991,331 |
Register and
explore Okredo data2024
Turnover (€)
1,665,695 €
-16 % *
Sales per employee (€)
200,445 €-11 % *
Profit before tax (€)
-85,888 €-130 % *
Net Profit (€)
-85,888 €-137 % *
Profit per employee (€)
-10,335 €-139 % *
Total profitability (%)
39.81 %-8.31 % *
Net profitability (%)
-5.16 %-144.03 % *
Equity (€)
939,516 €-14 % *
Amounts Payable And Liabilities (€)
1,096,952 €
85 % *
Non-current Assets (€)
50,816 €172 % *
CurrentAssets (€)
1,991,331 €19 % *